BR9709528A - Antiviral compounds - Google Patents

Antiviral compounds

Info

Publication number
BR9709528A
BR9709528A BR9709528A BR9709528A BR9709528A BR 9709528 A BR9709528 A BR 9709528A BR 9709528 A BR9709528 A BR 9709528A BR 9709528 A BR9709528 A BR 9709528A BR 9709528 A BR9709528 A BR 9709528A
Authority
BR
Brazil
Prior art keywords
antiviral compounds
antiviral
compounds
Prior art date
Application number
BR9709528A
Other languages
Portuguese (pt)
Inventor
Louis Nickolaus Jungheim
Timothy Alan Shepherd
Wayne Alfred Spitzer
Mark Joseph Tebbe
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9709528A publication Critical patent/BR9709528A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
BR9709528A 1996-06-05 1997-06-05 Antiviral compounds BR9709528A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1917096P 1996-06-05 1996-06-05
PCT/US1997/008848 WO1997046237A1 (en) 1996-06-05 1997-06-05 Anti-viral compounds

Publications (1)

Publication Number Publication Date
BR9709528A true BR9709528A (en) 1999-08-10

Family

ID=21791797

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709528A BR9709528A (en) 1996-06-05 1997-06-05 Antiviral compounds

Country Status (9)

Country Link
EP (1) EP0906097A4 (en)
JP (1) JP2000511899A (en)
KR (1) KR20000016346A (en)
CN (1) CN1220601A (en)
AU (1) AU3212897A (en)
BR (1) BR9709528A (en)
CA (1) CA2257296A1 (en)
EA (1) EA001316B1 (en)
WO (1) WO1997046237A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
AU6031898A (en) * 1997-01-22 1998-08-07 Eli Lilly And Company Anti-viral compounds
JP2002503253A (en) * 1997-06-04 2002-01-29 イーライ・リリー・アンド・カンパニー Antiviral compounds
EP1077701A4 (en) * 1998-05-20 2002-03-20 Lilly Co Eli Anti-viral compounds
ID30204A (en) * 1999-12-27 2001-11-15 Japan Tobacco Inc COMPOUNDS OF DIFFUSED RING AND ITS USE AS A MEDICINE
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
CN1829709A (en) 2003-08-01 2006-09-06 健亚生物科技公司 Bicyclic imidazol derivatives against flaviviridae
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
DE602005013922D1 (en) 2004-02-24 2009-05-28 Japan Tobacco Inc CONDENSED HETEROTETRACYCLIC COMPOUNDS AND THEIR USE AS HCV POLYMERASE INHIBITOR
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434288A (en) * 1982-04-08 1984-02-28 Eli Lilly And Company Preparation of substituted 1-thiazinyl or 1-thiazolyl-2-aminobenzimidazoles
US4420479A (en) * 1982-04-08 1983-12-13 Eli Lilly And Company Olefinic benzimidazoles, formulations, and antiviral methods
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles

Also Published As

Publication number Publication date
CN1220601A (en) 1999-06-23
CA2257296A1 (en) 1997-12-11
EA001316B1 (en) 2001-02-26
WO1997046237A1 (en) 1997-12-11
AU3212897A (en) 1998-01-05
EP0906097A1 (en) 1999-04-07
JP2000511899A (en) 2000-09-12
KR20000016346A (en) 2000-03-25
EP0906097A4 (en) 2000-12-13
EA199801078A1 (en) 1999-04-29

Similar Documents

Publication Publication Date Title
BR9709643A (en) Antiviral compounds
ID19403A (en) HETEROSICLIC COMPOUNDS
ID19609A (en) HETEROSICLIC COMPOUNDS
ID16152A (en) TRIARIL COMPOUNDS
ID15904A (en) TIOFENOPIRIMIDINE COMPOUNDS
PT860428E (en) PYRIMIDION COMPOUNDS
IS5479A (en) compounds
IS5478A (en) compounds
IS5477A (en) compounds
ID22850A (en) PIRAZINA COMPOUNDS
ID19476A (en) PYRIDYLPIROL COMPOUNDS
NO994877D0 (en) Calcilitic compounds
DE69716924D1 (en) Phosphonate-NUCLEOTIDE COMPOUNDS
ID20323A (en) TRIAZINILAMINOSTILBENA COMPOUNDS
ID18685A (en) SUBSTITUTED TRISICLIC COMPOUNDS
NO20005795D0 (en) Antiviral compounds
IS5208A (en) compounds
BR9705635A (en) Compounds
ID19490A (en) ANTIVIRAL COMBINATIONS
BR9709432A (en) Antiviral Compounds
DK0923594T3 (en) Bromothiacumicin compounds
BR9709528A (en) Antiviral compounds
DE69709659T2 (en) HALOPROPARGYL-INCLUSION COMPOUNDS
IS5237A (en) compounds
NO996544D0 (en) compounds

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]